RxDoctor Payments Data

Caitlin Ehlers, APRN

Family · Dixon, ILNPI 1538821541

Payments from drug & device makers

$863in general payments, 2019–2025

Across 42 payments — averaging $20.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$259
  • Novo Nordisk$161
  • Bayer$129
  • E.r. Squibb & Sons, L.L.C.$56
  • Teva Pharmaceuticals USA, Inc.$49
  • Lilly USA, LLC$42
  • plus $166 from 7 others

What the payments were for

  • Food & beverage$863100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$863 in reported general payments places this provider in the 70th percentile of 4,941 family providers in Illinois.

See all family providers in Illinois

Medicare billing

Part B allowed, 2024
$13,127
Medicare patients
90
Services billed
215

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RybelsusSemaglutide12$11,984
FarxigaDapagliflozin Propanediol12$10,317
JardianceEmpagliflozin11$7,458
Tresiba Flextouch U-100Insulin Degludec13$6,503
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr16$6,441
SymbicortBudesonide/Formoterol Fumarate11$2,335
Insulin Glargine-Yfgn12$1,080
Albuterol Sulfate HfaAlbuterol Sulfate39$837
SynthroidLevothyroxine Sodium11$772
Atorvastatin Calcium129$743
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine11$646
Lisinopril84$449
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen18$435
Famotidine25$389
Gabapentin16$317

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Symbicort$259$12,65223 claims
Novo NordiskRybelsus$161$11,98412 claims
AbbVieSynthroid$19$77211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,941 family providers in Illinois.

Other family in Dixon

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →